In rats and mice with diet-induced NASH, NRF2 activation improves glucose homeostasis and inhibits hepatic steatosis, inflammation, and fibrosis by decreasing lipid synthesis and upregulating β-oxidation and lipoprotein assembly [35,149]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.